Current Pharmaceutical Design
Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
   |
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Pharmaceutical Design, Volume 19 - Number 20
Invasive Aspergillosis in Children and Adolescents
, 19(20): 3545 - 3568Andreas H. Groll, Dominik Schrey, Athanasios Tragiannidis, Konrad Bochennek and Thomas Lehrnbecher
DOI: 10.2174/13816128113199990311
Invasive Aspergillosis: New Insights into Disease, Diagnostic and Treatment
, 19(20): 3569 - 3594Meinolf Karthaus and Dieter Buchheidt
DOI: 10.2174/13816128113199990330
Up-date on Diagnostic Strategies of Invasive Aspergillosis
, 19(20): 3595 - 3614Michaela Lackner and Cornelia Lass-Florl
DOI: 10.2174/13816128113199990323
Antifungal Therapy of Aspergillosis of the Central Nervous System and Aspergillus Endophthalmitis
, 19(20): 3648 - 3668Martin Hoenigl and Robert Krause
DOI: 10.2174/13816128113199990342
Immune Response, Diagnosis and Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis Lung Disease
, 19(20): 3669 - 3678Olaf Eickmeier, Nikolaus Rieber, Jonas Eckrich, Andreas Hector, Ute Graeppler-Mainka and Dominik Hartl
DOI: 10.2174/13816128113199990349
New Insights into Invasive Aspergillosis - from the Pathogen to the Disease
, 19(20): 3679 - 3688Ulrike Binder and Cornelia Lass-Florl
DOI: 10.2174/13816128113199990366
Immunotherapy in Invasive Fungal Infection - Focus on Invasive Aspergillosis
, 19(20): 3689 - 3712Thomas Lehrnbecher, Markus Kalkum, Jackson Champer, Lars Tramsen, Stanislaw Schmidt and Thomas Klingebiel
DOI: 10.2174/1381612811319200010
Transcriptomic Insights into the Oxidative Response of Stress-Exposed Aspergillus fumigatus
, 19(20): 3713 - 3737Emilie Frealle, Cecile-Marie Aliouat-Denis, Laurence Delhaes, David Hot and Eduardo Dei-Cas
DOI: 10.2174/1381612811319200011
Undressing the Fungal Cell Wall/Cell Membrane - the Antifungal Drug Targets
, 19(20): 3738 - 3747Rui Tada, Jean-Paul Latge and Vishukumar Aimanianda
DOI: 10.2174/1381612811319200012
Editor-in-Chief
William A. Banks
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
(USA)
Biography
View Full Editorial Board
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
Biography
Biography of William A. Banks
Dr. Banks obtained his MD from the University of Missouri- Columbia and did clinical and research training at the Veterans Affairs Medical Center – New Orleans and Tulane University. He is currently Associate Chief of Staff –Research and Development at the Puget Sound VA and Professor of Medicine at University of Washington School of Medicine. His main interest is in blood-brain barrier function. He has published over 450 non-abstract articles, and over 20,000 citations according to Web of Science with an H-index fo 81.
Nobel Laureate on Editorial Board
Andrew V. Schally
(USA)
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32
Advertisement
Webmaster Contact: info@benthamscience.net